These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 8116056)

  • 21. Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.
    Kabir S
    Vaccine; 2007 Feb; 25(8):1353-4. PubMed ID: 17049687
    [No Abstract]   [Full Text] [Related]  

  • 22. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
    Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
    J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity.
    Emch M; Ali M; Park JK; Yunus M; Sack DA; Clemens JD
    Int J Epidemiol; 2006 Aug; 35(4):1044-50. PubMed ID: 16723370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new inactivated oral cholera vaccine.
    Oberdoerster F; Thilo W
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):213-5. PubMed ID: 4440525
    [No Abstract]   [Full Text] [Related]  

  • 25. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events after oral vaccination against cholera with CVD103-HgR.
    Wiedermann G; Kollaritsch H; Jeschko E; Kundi M; Herzog C; Wegmüller B
    Wien Klin Wochenschr; 1998 May; 110(10):376-8. PubMed ID: 9654693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary conjoint statement on oral cholera vaccination.
    CMAJ; 1996 Oct; 155(8):1087-90. PubMed ID: 8873638
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholera treatment.
    Pierce NF; Robinson D; Rigal J; Dualeh M
    Lancet; 1994 Oct; 344(8928):1022. PubMed ID: 7802824
    [No Abstract]   [Full Text] [Related]  

  • 30. Prospects for control of cholera with oral vaccines.
    Sack RB
    J Diarrhoeal Dis Res; 1992 Mar; 10(1):1-3. PubMed ID: 1619235
    [No Abstract]   [Full Text] [Related]  

  • 31. [The current status of research on a cholera vaccine].
    Fournier JM
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The oral cholera vaccine project; the first 3 years of field work in Bangladesh].
    van Loon FP
    Ned Tijdschr Geneeskd; 1991 Jan; 135(3):87-9. PubMed ID: 1996165
    [No Abstract]   [Full Text] [Related]  

  • 34. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
    Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
    J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perspectives on cholera vaccines].
    Valdespino-Gómez JL; Isibasi-Araujo A; Hinojosa-Ahumada MA; Giono-Cerezo S
    Salud Publica Mex; 1993; 35(1):3-19. PubMed ID: 8470019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera control.
    Sack DA
    Lancet; 1994 Aug; 344(8922):616-7. PubMed ID: 7914984
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults.
    Valera R; García HM; Jidy MD; Mirabal M; Armesto MI; Fando R; García L; Fernández R; Año G; Cedré B; Ramírez M; Bravo L; Serrano T; Palma S; González D; Miralles F; Medina V; Nuñez F; Plasencia Y; Martínez JC; Mandarioti A; Lugones J; Rodríguez BL; Moreno A; González D; Baro M; Solis RL; Sierra G; Barbera R; Domínguez F; Gutiérrez C; Kouri G; Campa C; Menéndez J
    Vaccine; 2009 Nov; 27(47):6564-9. PubMed ID: 19720365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Committee to Advise on Tropical Medicine and Travel (CATMAT) and the National Advisory Committee on Immunization (NACI). Preliminary conjoint statement on oral cholera vaccination.
    Can Commun Dis Rep; 1996 May; 22(10):73-5. PubMed ID: 8696271
    [No Abstract]   [Full Text] [Related]  

  • 39. [A cholera vaccine has proven its efficacy during an epidemic in Guinea].
    Nau JY
    Rev Med Suisse; 2014 Jun; 10(434):1316-7. PubMed ID: 25073307
    [No Abstract]   [Full Text] [Related]  

  • 40. Cholera.
    CDR (Lond Engl Wkly); 1991 Jun; 1(25):111. PubMed ID: 1669856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.